A Study of OLR in First-line Treatment of Mantle Cell Lymphoma
Status:
Recruiting
Trial end date:
2023-10-15
Target enrollment:
Participant gender:
Summary
This is a single-arm, multicenter, open label phase II clinical study to evaluate the
efficacy and safety of OLR in the treatment of initially treated mantle cell lymphoma.
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital